Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 26-Apr-24
Select bar for recommendation details.
Recommendations | 26-Apr-24 | |
---|---|---|
Buy | 8 | |
Outperform | 16 | |
Hold | 5 | |
Underperform | 1 | |
Sell | 0 |
Share price forecast
The 26 analysts offering 12 month price targets for AstraZeneca plc have a median target of 13,147.67, with a high estimate of 17,697.07 and a low estimate of 6,226.58. The median estimate represents a 8.03% increase from the last price of 12,170.00.
High | 45.4% | 17,697.07 |
Med | 8.0% | 13,147.67 |
Low | -48.8% | 6,226.58 |
Dividends
Div growth (TTM) | 0.21% |
---|
More ▼
Earnings history & estimates
The next earnings announcement is expected on Jul 25, 2024.
Average growth rate | +4.58% |
Average growth rate | +20.34% |
More ▼
Revenue history & estimates
Average growth rate | +3.92% |
Average growth rate | +17.89% |
More ▼